This page is published in English as the authoritative version. Translations of headings are provided for convenience; the legal text below remains in English.
What MyDosha is, and what it is not.
MyDosha is an intake-summarisation and reference tool for qualified Ayurvedic practitioners. It is designed to reduce the administrative time practitioners spend preparing for a consultation by reorganising what a patient reports in an AI-guided intake, and by providing reference access to classical Ayurvedic literature and a curated formulary.
MyDosha is not a medical device. It is not intended for the diagnosis, prevention, monitoring, prediction, prognosis, treatment, or alleviation of disease. It does not provide clinical decision support within the meaning of EU Regulation 2017/745 (the Medical Device Regulation). It does not screen for drug interactions, flag safety concerns, recommend specific treatments, or classify a patient's constitution for clinical purposes.
What MyDosha does
- Patient intake — a conversational AI chatbot collects the patient's self-report across three phases: constitution indicators, lifestyle, and the patient's own description of their health concern. This is an electronic intake form with conversational UI.
- Intake summary — the AI reorganises the patient's own words into a practitioner-friendly document with sections covering the patient-reported constitutional pattern, imbalance signals, digestive pattern, srotas the patient's report points toward examining, and mental-pattern indicators. Every field is a reorganisation of self-report. No diagnosis. No classification. No recommendation.
- Practitioner note-taking fields — structured fields for the practitioner's own physical examination findings (ashtavidha pariksha: nadi, jihva, netra, sparsha, akriti, agni, ama, mala, mutra, manas) and the practitioner's own chikitsa plan (aushadha, ahara, vihara, panchakarma). The practitioner writes the content; MyDosha stores it.
- Classical formulary reference library — a curated list of classical Ayurvedic formulations with traditional indications, typical dosage ranges, and classical-source references. Presented as a reference library — the equivalent of an electronic textbook entry. The practitioner selects and prescribes according to their own clinical judgment.
- Classical text reference library — topically-indexed paraphrases of verses from Charaka Samhita, Sushruta Samhita, Ashtanga Hridayam, Bhavaprakasha, and Sharangadhara Samhita. Educational reference material, not clinical guidance.
- Herb-drug interactions reference library — a published-literature-derived reference table the practitioner can consult as part of their own safety screening. MyDosha does not perform the safety screen; the practitioner does.
- Practitioner chat reference librarian — an AI interface that answers the practitioner's questions by citing the reference libraries above. It does not make clinical recommendations, prescribe, or screen for safety.
- Patient portal — allows a patient to view their own intake answers and the practitioner-written care plan. A communication tool between practitioner and patient.
- Daily journal — lets a patient record subjective daily measures (energy, digestion, sleep, mood) as a log their practitioner may review. The practitioner interprets; MyDosha stores.
What MyDosha does not do
- MyDosha does not diagnose any disease, condition, or Ayurvedic clinical state.
- MyDosha does not recommend treatment, prescribe medications or formulations, or generate treatment plans.
- MyDosha does not perform drug-safety or herb-drug interaction screening for a specific patient. Reference literature is available in the library; applying it is the practitioner's clinical responsibility.
- MyDosha does not raise clinical red flags, urgency alerts, or contraindication warnings. The practitioner is the sole clinical decision-maker.
- MyDosha is not intended for use by patients without a qualified practitioner. The patient-facing intake is a preparation tool for a practitioner consultation.
Who MyDosha is for
MyDosha is intended for qualified Ayurvedic practitioners — BAMS-qualified doctors under India's Ministry of AYUSH framework, licensed Heilpraktiker practitioners in Germany operating within their professional scope, NAMA-aligned practitioners in the United States operating within their own state's scope of practice, and equivalent practitioners in other jurisdictions where Ayurveda is lawfully practised. Every trial signup requires the practitioner to confirm they are qualified in their jurisdiction and that all clinical decisions are theirs.
MyDosha is not intended for use by patients seeking self-diagnosis or self-treatment, and is not marketed to the general public as a health decision-making tool.
United States — regulatory notes
This section sets out MyDosha's regulatory position for users and practitioners in the United States. It is informational; it is not legal advice. Practitioners using MyDosha in the United States are responsible for ensuring their own practice complies with federal and state law, and we strongly recommend they consult their own attorney before relying on MyDosha in patient care.
FDA — MyDosha is not a medical device
MyDosha has not been evaluated, cleared, or approved by the U.S. Food and Drug Administration and is not intended to diagnose, treat, cure, mitigate, or prevent any disease. MyDosha is not "Software as a Medical Device" within the meaning of FDA guidance. Its functions fall within the non-device category described in the 21st Century Cures Act §3060 (codified at 21 U.S.C. §360j(o)) and the FDA's final guidance "Clinical Decision Support Software" (September 2022) on four grounds: (i) MyDosha does not acquire, process, or analyse a medical image, an in-vitro-diagnostic signal, or a pattern from a signal-acquisition system; (ii) MyDosha displays and reorganises patient self-report and curated reference material; (iii) any recommendation-shaped output is presented exclusively to a qualified healthcare practitioner, never to a patient as treatment guidance; and (iv) the basis of every AI-generated summary is transparently cited so that the practitioner can independently review the underlying patient-reported inputs and the curated knowledge sources. MyDosha does not perform patient-specific drug-interaction screening, urgency triage, or treatment recommendation, and we will not add those features without first re-evaluating device status.
FTC — health-product claims and AI disclosure
MyDosha does not make and does not authorise its customers to make therapeutic, curative, or disease-prevention claims about Ayurveda, Ayurvedic herbs, or any output generated by MyDosha. We comply with Federal Trade Commission §5 standards on health claims and with the FTC's published guidance on AI claims (2023–2025 enforcement). Every AI-generated output displayed in the practitioner portal is labelled as AI-generated; the practitioner is responsible for any communication of that output to a patient and for adding any disclosures required by their state's AI-in-healthcare laws (for example California AB 3030).
DSHEA — Ayurvedic herbs as dietary supplements
Where MyDosha references classical Ayurvedic formulations or herbs, those references are educational citations from classical literature (Charaka Samhita, Sushruta Samhita, Ashtanga Hridayam, Bhavaprakasha, Sharangadhara Samhita) and from a curated formulary. In the United States, Ayurvedic herbs are regulated as dietary supplements under the Dietary Supplement Health and Education Act (DSHEA, 1994), not as drugs. MyDosha does not recommend, prescribe, or dispense any herb for any specific patient. Practitioners who dispense herbs in the United States are independently responsible for complying with FDA supplement labelling and adulteration rules, including known FDA warnings about heavy-metal content in certain classical bhasma and rasa preparations.
HIPAA — coverage status
MyDosha does not currently offer a HIPAA Business Associate Agreement. MyDosha is therefore not appropriate for use with Protected Health Information by U.S. "covered entities" as defined under 45 C.F.R. §160.103 (for example, licensed providers who transmit electronic healthcare transactions covered by HIPAA, including Medicare/Medicaid claims). Most independent Ayurvedic practitioners in the United States are not HIPAA covered entities and are therefore not subject to HIPAA's Privacy and Security Rules. If you are a covered entity or a business associate of one, do not enter patient information into MyDosha — please contact hello@mydosha.org first. We treat practitioner and patient data with healthcare-grade safeguards regardless of HIPAA applicability (encryption in transit and at rest, audit logging, role-segregated access, append-only audit table, signed processor agreements with Supabase, Resend, Anthropic and Stripe).
FTC Health Breach Notification Rule
MyDosha treats itself as a "vendor of personal health records" subject to the FTC Health Breach Notification Rule, 16 C.F.R. Part 318 (as amended in 2024). Our published Consumer Health Data Privacy Policy describes what we collect, why, and from whom; the Privacy Policy describes how to exercise data-subject rights; and our internal Security Incident Response Runbook commits us to the Rule's 60-day individual-notification clock, 10-business-day FTC-notification clock for breaches affecting 500+ individuals, and the media-notification requirement for 500+ residents in a single U.S. state.
State unauthorized-practice-of-medicine laws
Ayurveda is not a state-licensed health profession in any U.S. state. A patchwork of "complementary and alternative medicine" safe-harbor statutes (e.g., California SB 577 and analogous statutes in MN, RI, AZ, NM, LA, NV, NC, OK) permits non-licensed practitioners to offer Ayurvedic services subject to specific written disclosure obligations. Outside those states, the scope of permissible Ayurvedic practice is narrower. MyDosha does not provide diagnosis, treatment recommendation, prescription, or pharmacy services, and its outputs must not be presented to patients as medical diagnosis, treatment, or prescription. Practitioners are solely responsible for understanding and complying with their own state's laws on unauthorized practice of medicine, unauthorized practice of pharmacy, scope of practice, title protection (the title "doctor" is restricted in several states), and any required client-disclosure forms. The note-fields formerly labelled "Prescription" in MyDosha's practitioner portal are now labelled "Care Plan Summary" to reflect that they are the practitioner's own clinical notes, not a pharmaceutical prescription.
State consumer-health-data and privacy laws
MyDosha complies with the Washington My Health My Data Act (effective March 31, 2024) and with analogous Nevada (SB 370) and Connecticut consumer-health-data provisions. Our Consumer Health Data Privacy Policy sets out: (i) what categories of consumer health data we collect and the specific purposes for collection; (ii) explicit, separate consent gates for collection and for sharing with the patient's practitioner; (iii) the right to deletion at any time, exercisable via the patient portal or by emailing privacy@mydosha.org; (iv) our commitment not to sell consumer health data and not to use the data for purposes beyond those consented to; (v) our commitment not to geofence health-care facilities; (vi) the categories of sub-processors with whom we share data and why. The Washington Act creates a private right of action under the Washington Consumer Protection Act (RCW 19.86); MyDosha accepts and respects this exposure as part of its responsibility for handling consumer health data. MyDosha also complies with the California Consumer Privacy Act and Privacy Rights Act, including the CPRA's automated-decision-making and sensitive-personal-information provisions; please see the Privacy Policy for the full account.
Testimonials and outcomes
Any testimonials or personal stories shown on MyDosha marketing pages reflect individual experiences. They are not medical claims, are not necessarily typical, and do not represent guaranteed outcomes from MyDosha or from any Ayurvedic approach.
Children
MyDosha is intended for use only by adults aged 18 and over. We do not knowingly collect personal information from anyone under 13, consistent with the Children's Online Privacy Protection Act (COPPA, 15 U.S.C. §§6501–6506). Practitioners must not use MyDosha with patients under 18.
Liability
The practitioner is responsible for all clinical decisions made in reliance on, or with reference to, any information MyDosha displays. MyDosha provides the practitioner with a reorganised view of patient-reported information and curated reference material. It does not substitute for the practitioner's own training, judgment, or physical examination of the patient. See our Terms of Service for the full contractual basis.
Data protection
Patient intake data is stored in Supabase (US-based processor on AWS infrastructure; transfers covered by EU Standard Contractual Clauses, Commission Decision 2021/914), accessed only by the treating practitioner and MyDosha operational staff for support. Explicit patient consent is obtained at intake. Patients can request export or deletion of their record at any time. See Privacy Policy for the full GDPR basis.
AI disclosure
Several MyDosha features use large language models (Anthropic's Claude family). Outputs are generated probabilistically and may contain errors, omissions, or phrasing that does not match the source material exactly. Every AI-generated output is labelled, and the practitioner is expected to read the outputs as an assisted reorganisation — not as authoritative content. Under Regulation (EU) 2024/1689 (the AI Act), MyDosha does not qualify as a high-risk AI system because it is not a medical device and is not listed in Annex III.
Questions about this statement, or a regulator wanting a written qualification opinion? Email hello@mydosha.org.
Last updated: 2026-04-28. MyDosha is a product of MyTrueDosha (operating brand) / Thomas Thijs, Sorano, Italy.